Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.
NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial NCT06841731 remains recruiting per ClinicalTrials.gov and recent publications as of 2026. No public readout of Phase 2 results available; estimated primary completion 2026-02-01. Early PK and Phase 2 cUTI data exist, but nothing trial-specific.
Found Apr 6, 2026, 2:57 PMReviewed Apr 6, 2026, 3:00 PM
NO_DECISIONDismissed95% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial NCT06841731 is recruiting with estimated primary completion in 2026-02-01. No efficacy results, readout, or public interpretation available. All sources confirm it is ongoing with data unpublished.
Found Apr 6, 2026, 2:12 PMReviewed Apr 6, 2026, 2:19 PM
NO_DECISIONDismissed90% confidencemanual-chat-review
Will the results be positive?
ClinicalTrials.gov still lists this study as recruiting with no posted results, so there is not yet a clear public positive or negative trial readout.
Found Apr 4, 2026, 8:54 PMReviewed Apr 4, 2026, 10:33 PM
NO_DECISIONDismissed97% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific efficacy readout was found. ClinicalTrials.gov shows NCT06841731 is still recruiting, with “No Results Posted,” actual start on 2025-04-03, and estimated primary completion in February 2026. Hengrui’s 2025 interim report lists HRS-8427 in HABP/VABP with reporting-period progress: none.
Found Apr 1, 2026, 6:49 PMReviewed Apr 1, 2026, 7:04 PM
ClinicalTrialsclinicaltrials.govApr 22, 2025, 12:00 AM
Study Details | NCT06841731 | A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia
ClinicalTrials.gov lists the Phase 2 HABP/VABP study as recruiting, shows “No Results Posted,” actual study start 2025-04-03, and estimated primary completion in February 2026.
Sponsorhkexnews.hkSep 26, 2025, 12:00 AM
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Interim Report 2025
In the product pipeline table, HRS-8427 for hospital-acquired and ventilator-associated bacterial pneumonia is listed in Phase II, with “Progress during the Reporting Period: None.”